What waiving vaccine patent rights might mean for big pharma
Ask students: Who controls the patents on coronavirus vaccines? Why is the U.S. government considering waiving these patents?
Share
May 10, 2021
Ask students: Who controls the patents on coronavirus vaccines? Why is the U.S. government considering waiving these patents?
Share
Read the summary, watch the video and answer the discussion questions below. To read the transcript of the video below, click here. Updated: To make clear that the U.S. has not officially waived any patents at this time.
Key term: Patent - “A patent is a right granted to an inventor by the federal government [United States Patent and Trademark Office – USPTO] that permits the inventor to exclude others from making, selling or using the invention for a period of time…Congress was given the power to grant patents in the Constitution, and federal statutes and rules govern patents.” (Source: FindLaw.com)
Summary: President Joe Biden has given an early sign that the U.S. might waive patent rights on COVID vaccines to boost international production. But there are real questions over how effective these moves would be, what other countries feel about it, and when this would translate into action.
Discussion:
Warm up questions: Have your students identify the 5Ws and an H:
Then have students share with the class or through a Learning Management System (LMS).
Focus question: Do you think the U.S. should put significant resources into getting the rest of the world vaccinated? Why do you think so?
Media literacy: Who else would you want to hear from to better understand the reasoning behind sharing or not sharing vaccine manufacturing technology and paying drug companies to speed up global vaccinations?
Dig Deeper:
Republished with permission from PBS Newshour Extra